Fermented Soybean Supplementation Among Active Pulmonary Tuberculosis Patients With Standard Therapy in Indonesia

NCT ID: NCT02554318 Phase: NA Status: COMPLETED Enrollment: 147 Completion: 2015-02

Conditions

Pulmonary Tuberculosis, Body Weight Changes, Motor Activity

Interventions

Rifampicin, Isoniazid, Pyrazinamide, Ethambutol, Fermented soybean

Summary

Tuberculosis (TB) patients often have a lower body mass index (BMI) and experience wasting. Wasting reduces lean body mass and may cause physical function impairment. This study aimed to determine the efficacy of fermented soybeans (tempeh) as a food supplement on body weight and physical function changes among active pulmonary tuberculosis patients with standard therapy.

Primary Outcome

Change in Bodyweight on a Digital Weight Scale From Baseline at 2 Months

Source

ClinicalTrials.gov